Dechra Pharmaceuticals (DPH)

 

Broker Forecast - Cantor Fitzgerald issues a broker note on Dechra Pharmaceuticals PLC

Cantor Fitzgerald today reaffirms its buy investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 2200p (from 1500p).